As anticipated, those with NAFLD had increased indices of adiposity and decreased insulin sensitivity and hepatic insulin extraction compared to those with normal liver fat content, with a higher ALT, composite metabolic risk score and worse lipid profiles. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.